Multiple Sclerosis Trial, Recruiting (NCT06526364)

Multiple Sclerosis Trial, Recruiting NCT06526364 Sponsor: University Hospital, Basel, Switzerland Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06526364 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older
You must be willing and able to follow the study requirements, including providing data and samples and attending study visits
You must be willing to sign a consent form agreeing to take part
You must own a smartphone that works with the Healios+Me app (iPhone or Android)
You must have close-up vision of at least a certain level, even with glasses or contact lenses (confirm with trial site)
You must have enough hand coordination and movement to use a smartphone
You must be able to understand and follow the study procedures
You must have been diagnosed with Multiple Sclerosis (MS) according to specific guidelines, including any form of MS (such as relapsing-remitting, secondary progressive, or primary progressive MS, or an early first episode), AND either be in the early stages of the disease (diagnosed less than 3 years ago) or be moving into a progressive stage of the disease as assessed by a standard MS disability scale (confirm with trial site)
You must already be a patient at the MS Centre at University Hospital Basel

Who may not be able to join:

There are no specific exclusion criteria listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cristina Granziera, Prof., Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB)

Phone: +41 79 961 26 31

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06526364

Sponsor: University Hospital, Basel, Switzerland

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +41 79 961 26 31

More information: https://clinicaltrials.gov/study/NCT06526364

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older
You must be willing and able to follow the study requirements, including providing data and samples and attending study visits
You must be willing to sign a consent form agreeing to take part
You must own a smartphone that works with the Healios+Me app (iPhone or Android)
You must have close-up vision of at least a certain level, even with glasses or contact lenses (confirm with trial site)
You must have enough hand coordination and movement to use a smartphone
You must be able to understand and follow the study procedures
You must have been diagnosed with Multiple Sclerosis (MS) according to specific guidelines, including any form of MS (such as relapsing-remitting, secondary progressive, or primary progressive MS, or an early first episode), AND either be in the early stages of the disease (diagnosed less than 3 years ago) or be moving into a progressive stage of the disease as assessed by a standard MS disability scale (confirm with trial site)
You must already be a patient at the MS Centre at University Hospital Basel

Who may not be able to join:

There are no specific exclusion criteria listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Basel, Switzerland

Registry

ClinicalTrials.gov

Start date

10 December 2024

Est. completion

1 June 2029

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Set of biomarkers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov